We use a session cookie and first-party analytics to run this site — no third-party trackers, no ads. Details in our Privacy Policy.
RESEARCH From the Research Desk — The sub-Rs 100 crore acquisition market, sized. Read it →
Home/ Cases/ Pharmaceuticals/ KRUX Pharma Private Limited
● UNDER CIRP

KRUX Pharma Private Limited

Corporate insolvency resolution — proceedings ongoing · source: IBBI list of newly admitted cases

Business: pharmaceutical manufacture; oral tablets and capsules at Balda, Valsad confirmed by regulatory facility list. · 9 years old at admission

Sector Pharmaceuticals Bench NCLT Ahmedabad CIN U24302GJ2016PTC094103 Admitted 7 Aug 2026 Initiated by OC — Orbit Lifescience Private Limited Last process activity 21 Aug 2026 · claims re-verified · active
OWED MONEY BY THIS COMPANY?
The date in the public announcement passed on 21 Aug 2026, but the window has not shut. Regulation 12 lets a creditor file up to 5 Nov 2026 — 30 days left — ninety days from admission on 7 Aug 2026, or later still if the request for resolution plans has not yet gone out. File with Jayesh Natvarlal Sanghrajka now.
Reg. 12, IBBI (CIRP) Regulations 2016
How to file your claim → The professional’s record →

Case record

the public record

Corporate insolvency record of KRUX Pharma Private Limited, commenced 7 Aug 2026, at NCLT Ahmedabad, initiated by OC Orbit Lifescience Private Limited. Current status: Under CIRP.

CIN
U24302GJ2016PTC094103
Incorporated
2016
Registered State
Gujarat
NCLT Bench
Ahmedabad
Initiated by
OC Orbit Lifescience Private Limited
Public Announcement
11 Aug 2026
Commencement
7 Aug 2026
Sector
Pharmaceuticals
Resolution Professional
Jayesh Natvarlal Sanghrajka →
Subscriber access

Full case intelligence is gated

This page's financial detail is available to stressed.in subscribers — for ARCs, PE funds and resolution professionals.

Admitted claims Recovery waterfall & haircut Sector benchmarks Case timeline & professionals Committee of creditors Plan value & CoC vote Intelligence note
See plans →
Just this company — Rs 1,799 · apply for access →

One company, bought outright — yours permanently, including future updates. Subscribe within 30 days and the whole Rs 1,799 comes off your first month, so starting with one case costs nothing against subscribing later.

Questions? WhatsApp us →
Other Pharmaceuticals cases
Nadhi Bio Products Private Limited
Resolved
Saffron Therapeutics Private Limited
Resolved
Bionext Pharma Private Limited
Resolved
Sources, basis and disclaimers → ·
report an error